Sterner, R. M., Sakemura, R., Yang, N., Cox, M. J., Khadka, R., Forsman, C. L., … Kenderian, S. S. (2019). GM-CSF Blockade during Chimeric Antigen Receptor T-Cell (CART) Therapy Reduces Cytokine Release Syndrome and Neurotoxicity and May Enhance CART Effector Functions. Biology of Blood and Marrow Transplantation, 25(3), S4–S4. https://doi.org/10.1016/j.bbmt.2018.12.686

Sterner, Rosalie M., Reona Sakemura, Nan Yang, Michelle J. Cox, Roman Khadka, Cynthia L. Forsman, Michael J. Hansen, et al. “GM-CSF Blockade during Chimeric Antigen Receptor T-Cell (CART) Therapy Reduces Cytokine Release Syndrome and Neurotoxicity and May Enhance CART Effector Functions.” Biology of Blood and Marrow Transplantation 25, no. 3 (March 2019): S4–S4. https://doi.org/10.1016/j.bbmt.2018.12.686.

Sterner RM, Sakemura R, Yang N, Cox MJ, Khadka R, Forsman CL, et al. GM-CSF Blockade during Chimeric Antigen Receptor T-Cell (CART) Therapy Reduces Cytokine Release Syndrome and Neurotoxicity and May Enhance CART Effector Functions. Biology of Blood and Marrow Transplantation. 2019 Mar;25(3):S4–S4.

Sterner, Rosalie M., et al. “GM-CSF Blockade during Chimeric Antigen Receptor T-Cell (CART) Therapy Reduces Cytokine Release Syndrome and Neurotoxicity and May Enhance CART Effector Functions.” Biology of Blood and Marrow Transplantation, vol. 25, no. 3, Elsevier BV, Mar. 2019, pp. S4–S4. Crossref, doi:10.1016/j.bbmt.2018.12.686.

Sterner RM, Sakemura R, Yang N, Cox MJ, Khadka R, Forsman CL, Hansen MJ, Jin F, Ayasoufi K, Hefazi M, Welch BM, Schick KJ, Walters DK, Martinez G, Ahmed O, Sahmoud T, Durrant C, Nevala WK, Patnaik MM, Russell SJ, Pease LR, Kay NE, Hedin KE, Johnson AJ, Kenderian SS. GM-CSF Blockade during Chimeric Antigen Receptor T-Cell (CART) Therapy Reduces Cytokine Release Syndrome and Neurotoxicity and May Enhance CART Effector Functions. Biology of Blood and Marrow Transplantation. Elsevier BV; 2019 Mar;25(3):S4–S4.